Medicare Enrolled

Dr. Roberto Viguilla, M.D.

Family Medicine · Roscommon, MI
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
135 LAKE ST, Roscommon, MI 48653
9892758931
In practice since 2005 (20 years)
NPI: 1013992536 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Viguilla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Viguilla? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Viguilla

Dr. Roberto Viguilla is a family medicine specialist in Roscommon, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Viguilla performed 146 Medicare services across 82 unique beneficiaries.

Between the years covered by Open Payments, Dr. Viguilla received a total of $4,609 from 27 pharmaceutical and/or device companies across 279 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Viguilla is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 146 Medicare services $4,609 industry payments

Medicare Practice Summary

Medicare Utilization ↗
146
Medicare services
Bottom 26% in MI for family medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
82
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~7 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
3D screening mammography (tomosynthesis)
A screening imaging test of the breast using 3D technology to detect potential abnormalities.
 54 $25 $52
Screening mammography
An X-ray of the breast used to detect breast cancer in women who have no signs or symptoms of the disease.
 54 $60 $141
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
 26 $2 $7
Routine 12-lead electrocardiogram (ECG)
A test that records the electrical activity of the heart using at least 12 leads to produce a tracing.
 12 $3 $30
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,609
Total received (2018-2024)
Avg $658/year across 7 years
Top 9% in MI for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
279
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,609 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$898
2023
$338
2022
$901
2021
$760
2020
$253
2019
$658
2018
$801

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$234
AstraZeneca Pharmaceuticals LP
$182
Novo Nordisk Inc
$146
Amgen Inc.
$87
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$48
Lilly USA, LLC
$46
Novartis Pharmaceuticals Corporation
$39
Boehringer Ingelheim Pharmaceuticals, Inc.
$38
Corium, LLC
$19
GlaxoSmithKline, LLC.
$16
Mylan Specialty L.P.
$15
PFIZER INC.
$14
Exact Sciences Corporation
$14
Top 3 companies account for 62.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$847
ABBVIE INC.
$588
Novo Nordisk Inc
$524
Lilly USA, LLC
$416
Amgen Inc.
$361
SANOFI-AVENTIS U.S. LLC
$310
Boehringer Ingelheim Pharmaceuticals, Inc.
$238
GlaxoSmithKline, LLC.
$182
Mylan Specialty L.P.
$141
Merck Sharp & Dohme Corporation
$139
AbbVie Inc.
$131
PFIZER INC.
$129
Janssen Pharmaceuticals, Inc
$89
Takeda Pharmaceuticals U.S.A., Inc.
$66
Esperion Therapeutics, Inc.
$61
Sunovion Pharmaceuticals Inc.
$56
Novartis Pharmaceuticals Corporation
$55
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$48
Merck Sharp & Dohme LLC
$40
E.R. Squibb & Sons, L.L.C.
$37
Exact Sciences Corporation
$29
Bayer HealthCare Pharmaceuticals Inc.
$29
Kowa Pharmaceuticals America, Inc.
$26
Teva Pharmaceuticals USA, Inc.
$21
Corium, LLC
$19
Bayer Healthcare Pharmaceuticals Inc.
$16
Allergan Inc.
$12
Top 3 companies account for 42.5% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · AUSTEDO · Amitiza · Azstarys · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · CAPLYTA · CHANTIX · COLOGUARD · Cologuard Collection Kit · ELIQUIS · EMGALITY · ENTRESTO · FARXIGA · HUMALOG · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LONHALA MAGNAIR · LYRICA · Livalo · MOUNJARO · NEXLETOL · Otezla · Ozempic · PREVNAR - 13 · Perforomist · QULIPTA · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · Saxenda · Seglentis · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tresiba · UBRELVY · UTIBRON · Utibron · VRAYLAR · Victoza · Wegovy · XARELTO · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for family medicine in MI.

Looking for a family medicine specialist in Roscommon?
Compare family medicine physicians in the Roscommon area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
28
Per 100K population
118.4
County median income
$54,106
Nearest hospital
MUNSON HEALTHCARE GRAYLING HOSPITAL
14.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Viguilla is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 9% of MI peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Viguilla experienced with 3d screening mammography (tomosynthesis)?
Based on Medicare claims data, Dr. Viguilla performed 54 3d screening mammography (tomosynthesis) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Viguilla receive payments from pharmaceutical companies?
Yes. Dr. Viguilla received a total of $4,609 from 27 companies across 279 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Viguilla's costs compare to other family medicine physicians in Roscommon?
Dr. Viguilla's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Viguilla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Roscommon
Browse family medicine physicians in Roscommon ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in MI
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in MI
Which MI family medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →